Annual Shareholders Equity
$52.41 M
-$68.03 M-56.48%
December 31, 2022
Summary
- As of February 10, 2025, FRLN annual stockholders equity is $52.41 million, with the most recent change of -$68.03 million (-56.48%) on December 31, 2022.
- During the last 3 years, FRLN annual shareholders equity has fallen by -$32.54 million (-38.30%).
Performance
FRLN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$30.04 M
-$11.98 M-28.50%
September 1, 2023
Summary
- As of February 10, 2025, FRLN quarterly stockholders equity is $30.04 million, with the most recent change of -$11.98 million (-28.50%) on September 1, 2023.
- Over the past year, FRLN quarterly shareholders equity has dropped by -$38.54 million (-56.20%).
Performance
FRLN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
FRLN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.5% | -56.2% |
| 3 y3 years | -38.3% | - |
| 5 y5 years | +128.2% | -64.6% |
FRLN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.5% | at low | -75.1% | at low |
| 5 y | 5-year | -79.0% | at low | -88.0% | at low |
| alltime | all time | -79.0% | -56.2% | -88.0% | at low |
Freeline Therapeutics Holdings Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $30.04 M(-28.5%) |
| Jun 2023 | - | $42.02 M(-25.0%) |
| Mar 2023 | - | $55.99 M(+6.8%) |
| Dec 2022 | $52.41 M(-56.5%) | $52.41 M(-23.6%) |
| Sep 2022 | - | $68.58 M(-23.5%) |
| Jun 2022 | - | $89.63 M(-24.4%) |
| Mar 2022 | - | $118.56 M(-1.6%) |
| Dec 2021 | $120.44 M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | - | $120.44 M(-21.2%) |
| Sep 2021 | - | $152.80 M(-17.7%) |
| Jun 2021 | - | $185.63 M(-15.4%) |
| Mar 2021 | - | $219.43 M(-12.2%) |
| Dec 2020 | $249.80 M(+194.0%) | - |
| Dec 2020 | - | $249.80 M(+110.0%) |
| Jun 2020 | - | $118.98 M(+40.0%) |
| Dec 2019 | $84.96 M(+269.8%) | $84.96 M |
| Dec 2018 | $22.97 M | - |
FAQ
- What is Freeline Therapeutics Holdings annual stockholders equity?
- What is the all time high annual shareholders equity for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings annual shareholders equity year-on-year change?
- What is Freeline Therapeutics Holdings quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings quarterly shareholders equity year-on-year change?
What is Freeline Therapeutics Holdings annual stockholders equity?
The current annual shareholders equity of FRLN is $52.41 M
What is the all time high annual shareholders equity for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high annual stockholders equity is $249.80 M
What is Freeline Therapeutics Holdings annual shareholders equity year-on-year change?
Over the past year, FRLN annual stockholders equity has changed by -$68.03 M (-56.48%)
What is Freeline Therapeutics Holdings quarterly stockholders equity?
The current quarterly shareholders equity of FRLN is $30.04 M
What is the all time high quarterly shareholders equity for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high quarterly stockholders equity is $249.80 M
What is Freeline Therapeutics Holdings quarterly shareholders equity year-on-year change?
Over the past year, FRLN quarterly stockholders equity has changed by -$38.54 M (-56.20%)